Observational (n=10)
Daptomycin-induced eosinophilic pneumonitis is a rare but potentially fatal complication occurring in 1.7% of courses, highlighting the need for active respiratory monitoring in older patients on prolonged therapy.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Conway-Jones et al. (2026) conducted an observational in Daptomycin-induced eosinophilic pneumonitis (n=10). Daptomycin was evaluated on Development of eosinophilic pneumonitis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: